Withacnistin inhibits recruitment of STAT3 and STAT5 to growth factor and cytokine receptors and induces regression of breast tumours

BACKGROUND: The binding of STAT3 and STAT5 to growth factor and cytokine receptors such as EGFR and IL-6 receptor gp130 is critical to their activation and ability to contribute to malignant transformation. Therefore, interfering with these biochemical processes could lead to the discovery of novel...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, X, Blaskovich, M A, Forinash, K D, Sebti, S M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150266/
https://www.ncbi.nlm.nih.gov/pubmed/24983364
http://dx.doi.org/10.1038/bjc.2014.349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150266/
https://www.ncbi.nlm.nih.gov/pubmed/24983364
http://dx.doi.org/10.1038/bjc.2014.349

Ejemplares similares